Gilead Sciences, Inc.
Gilead Sciences, Inc. scores highest on Nitro (96) and lowest on Price (4). Its PosiPenta is 54.25 out of 100, around the middle of similar companies.
On the Penta Grid this week, Gilead Sciences, Inc. is Grid #224 of 837 in the Healthcare sector in United States, and Grid #1,358 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 54.25 | 4 | 62 | 96 | 37 | 73 |
| Abbott Laboratories | 64.43 | 37 | 83 | 75 | 55 | 72 |
| Pfizer Inc. | 70.97 | 44 | 88 | 98 | 52 | 74 |
| Danaher Corporation | 68.58 | 34 | 79 | 93 | 55 | 82 |
| Amgen Inc. | 64.83 | 26 | 78 | 96 | 52 | 73 |
| Intuitive Surgical, Inc. | 58.62 | 18 | 72 | 68 | 88 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -58.94 |
| P/B ratio | 16.37 |
EEarnings
| Trailing EPS | ₹-250.99 |
| Forward EPS | ₹941.76 |
NNitro
| Price | 14793.53 |
| 52-week high | 15202.70 |
| 52-week low | 10799.40 |
| Fall from 52-week high | 2.7% |
TTorque
| Return on equity (ROE) | -20.68% |
| Debt-to-equity | 2.23 |
AAnchor
| Beta (price swings) | 0.33 |
| Market cap | ₹18,34,331 Cr |
| Insider holding | 0.11% |
| Dividend yield | 2.08% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Gilead Sciences, Inc.'s PosiPenta score?
Gilead Sciences, Inc.'s PosiPenta is 54.25 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Gilead Sciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Gilead Sciences, Inc. is Grid #224 of 837 in the Healthcare sector in United States, and Grid #1,358 of 4,000 in United States.
Which PosiPenta pillar is strongest for Gilead Sciences, Inc.?
Nitro (momentum), with a score of 96 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Gilead Sciences, Inc.?
Price (valuation), with a score of 4 out of 100: much weaker than most similar companies.
Has Gilead Sciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 10.67 points, from 43.58 to 54.25.
PositoAI is for research and education only and is not investment advice.